Jennifer Jarrett insider trades
Open-market stock purchases and sales by Jennifer Jarrett, Director, President and CEO at Damora Therapeutics, Inc, from SEC Form 4 filings since Apr 7, 2016.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +7%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 25, 2026 | DMRA Damora Therapeutics, Inc | Bought | $253K |
| Jun 17, 2026 | ZURA Zura Bio Ltd | Bought (not open market) | — |
| Jun 12, 2026 | SGMT Sagimet Biosciences Inc | Bought (not open market) | — |
| Mar 30, 2026 | DMRA Damora Therapeutics, Inc | Bought (not open market) | — |
| Mar 30, 2026 | DMRA Damora Therapeutics, Inc | Bought (not open market) | — |
| Feb 4, 2026 | SNDX Syndax Pharmaceuticals Inc | Bought (not open market) | — |
| Jan 23, 2026 | RCUS Arcus Biosciences, Inc | Bought (not open market) | — |
| Jan 23, 2026 | RCUS Arcus Biosciences, Inc | Bought (not open market) | — |
| Dec 17, 2025 | RCUS Arcus Biosciences, Inc | Sold | $221K |
| Dec 16, 2025 | RCUS Arcus Biosciences, Inc | Sold | $246K |
| Nov 7, 2025 | RCUS Arcus Biosciences, Inc | Sold | $954K |
| Nov 7, 2025 | RCUS Arcus Biosciences, Inc | Bought (not open market) | $61.7K |
Companies traded
- DMRA Damora Therapeutics, Inc: 1 buy, last Sep 25, 2026
- ZURA Zura Bio Ltd: other filings, last Jun 17, 2026
- SGMT Sagimet Biosciences Inc: other filings, last Jun 12, 2026
- SNDX Syndax Pharmaceuticals Inc: other filings, last Feb 4, 2026
- RCUS Arcus Biosciences, Inc: 44 sales, last Jan 23, 2026
- RDUS Radius Health, Inc: other filings, last Aug 15, 2022
- ARNA Arena Pharmaceuticals Inc: other filings, last Mar 11, 2022
- SRZN Surrozen, Inc./DE: other filings, last Aug 11, 2021
- BOLD Audentes Therapeutics, Inc: other filings, last Jan 15, 2020
- MDVN Medivation, Inc: other filings, last Sep 28, 2016